Preoperative Transarterial Embolization of Advanced Juvenile Nasopharyngeal Angiofibroma Using N-Butyl Cyanoacrylate: Case-Control Comparison with Microspheres.

Qiang Liu,Wanpeng Li,Rujian Hong,Yucheng Pan,Kai Xue,Quan Liu,Xicai Sun,Houyong Li,Yan Sha,Hongmeng Yu,Dehui Wang

DOI: https://doi.org/10.1016/j.jvir.2023.01.011

IF: 3.682

2023-01-01

Journal of Vascular and Interventional Radiology

Abstract:PURPOSE:To evaluate the efficacy and safety of transarterial embolization (TAE) with n-butyl cyanoacrylate (nBCA) for juvenile nasopharyngeal angiofibroma (JNA).MATERIALS AND METHODS:A retrospective review was performed on patients with JNA who underwent TAE and endoscopic resection between 2020 and 2022. Patients embolized with nBCA were identified, and those embolized with microspheres were set as the control group. Data on demographics, symptoms, tumor characteristics, blood loss, adverse events, residual disease, and recurrence were collected, and case-control analysis was performed for the 2 groups. Differences in characteristics between the groups were tested using the Fisher exact and Wilcoxon tests. A generalized linear model (GLM) was used to analyze the univariate and multivariate influences on blood loss.RESULTS:Twenty patients were included in this study: 13 in the microsphere group and 7 in the nBCA group. The median blood loss was 400 mL (interquartile range [IQR], 200-520 mL) in the nBCA group and 1,000 mL (IQR, 500-1,000 mL) in the microsphere group (P = .028). The GLM confirmed lower blood loss in the nBCA group (relative risk, 0.58 [0.41-0.83]; P = .01). A residual tumor was found in 1 patient in each group (7.7% vs 14.3%; P = 1.000). Recurrence was not observed in any patient. None of the patients experienced adverse events during embolization.CONCLUSIONS:TAE of advanced JNA with nBCA glue is safe and effective and can significantly reduce intraoperative blood loss compared with microspheres.